Organon shareholders approve Sun Pharma's $11.75 billion acquisition, paving the way for it to become a wholly owned subsidiary.
SENSEX 76,059.77
NIFTY 23,767.45
CRUDEOIL 8,673.00
GOLD 143,363.00
+ 542.00
Sun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone…
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that…
Sun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales…
With the purchase of Organon & Co., billionaire Dilip Shanghvi's Sun Pharmaceutical Industries' annual revenue will more than…
India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in…
A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could stand in the way of…
